SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905148-24-001709
Filing Date
2024-06-13
Accepted
2024-06-13 17:23:21
Documents
2
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5597
2 ainsworth_poa.htm EX-24 9457
  Complete submission text file 0000905148-24-001709.txt   16718
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Issuer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 37000 GRAND RIVER AVE SUITE 120 FARMINGTON HILLS MI 48335
Business Address
Ainsworth Sean (Reporting) CIK: 0001830296 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34079 | Film No.: 241042214